Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
184
184 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- IAM1363Phase 21 trial
Iambic Therapeutics, Inc · HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer
- IMT-009Phase 21 trial
Immunitas Therapeutics · Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer
- INV-6452Phase 21 trial
Shenzhen Ionova Life Sciences Co., Ltd. · Breast Cancer (Locally Advanced or Metastatic), Advanced Solid Cancers, Metastatic (Stage IV) Breast Cancer
- INX-315Phase 21 trial
Incyclix Bio · Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor
- IOV-5001Phase 21 trial
Iovance Biotherapeutics, Inc. · Advanced Solid Tumors, Non-Small Cell Lung Cancer, Triple Negative Breast Cancer (TNBC)
- JAB-2485Aurora A inhibitorPhase 21 trial
Jacobio Pharmaceuticals Co., Ltd. · Solid Tumors, ER+ Breast Cancer, Triple Negative Breast Cancer, TNBC
- KC1086Phase 21 trial
Beijing Konruns Pharmaceutical Co., Ltd. · HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer
- KVA12123Phase 21 trial
Kineta Inc. · Cancer, Solid Tumor, Melanoma
- LG00313112Phase 21 trial
LG Chem · Ovarian Cancer, Small Cell Lung Cancer, Non Small Cell Lung Cancer
- LP-184Phase 21 trial
Lantern Pharma Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, GBM
- MDSY-1240Phase 21 trial
Medsyn Biopharma, LLC · Triple-Negative Breast Cancer (TNBC), Gastric Cancer (GC), Gastric Cancer Adenocarcinoma Metastatic
- MDX2001Phase 21 trial
ModeX Therapeutics, An OPKO Health Company · Biliary Tract Cancer, Breast Cancer, Cervical Cancer
- MT-4561Phase 21 trial
Tanabe Pharma America, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Non-small Cell Lung Cancer (NSCLC), Esophageal Cancer
- Nab-placlitaxelPhase 21 trial
BioNTech SE · Locally Advanced Breast Cancer, Triple Negative Breast Cancer, Metastatic Triple Negative Breast Cancers
- NadunolimabCAN04Phase 21 trial
Cantargia AB · Triple Negative Breast Cancer
- NBQ72SQBS10072SPhase 21 trial
Nantong Bencao Quadriga Medical Technology Co. Ltd. · Breast Cancer
- NUV-1511Phase 21 trial
Nuvation Bio Inc. · Advanced Solid Tumor, HER2-negative Breast Cancer, Metastatic Castration-resistant Prostate Cancer (mCRPC)
- PF-0704091Phase 21 trial
Pfizer · Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer
- PMD-026Phase 21 trial
Phoenix Molecular Designs · Metastatic Breast Cancer
- QLS1304Phase 21 trial
Qilu Pharmaceutical Co., Ltd. · Advanced ER+/HER2- Breast Cancer
- RO0091978Phase 21 trial
Roche (Genentech) · Metastatic Breast Cancer
- Sequential EpirubicinPhase 21 trial
RemeGen Co., Ltd. · Breast Cancer
- SMP-656Phase 21 trial
Chengdu SciMount Pharmatech Co., Ltd. · HER2-positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer (LABC)
- SNS-101anti-VISTAPhase 21 trial
Sensei Biotherapeutics, Inc. · Solid Tumor, Adult, Advanced Solid Tumor, Head and Neck Cancer
- ST-067Phase 21 trial
Simcha IL-18, Inc. · Cancer, Solid Tumor, Melanoma
- ST101Phase 21 trial
Sapience Therapeutics · Glioblastoma, Melanoma Stage IV, Breast Cancer
- SYHX2011Phase 21 trial
CSPC Ouyi Pharmaceutical Co., Ltd. · Advanced Breast Cancer
- SYS6023Phase 21 trial
CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Breast Cancer
- TenalisibRP6530Phase 21 trial
Rhizen Pharmaceuticals SA · Triple Negative Breast Cancer (TNBC)
- TER-2013Phase 21 trial
Terremoto Biosciences Inc. · Breast Cancer, Endometrial Cancer, Ovarian Cancer
- TQB3126Phase 21 trial
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Breast Cancer
- TUB-030Phase 21 trial
Gilead Sciences · Advanced Solid Tumors, HNSCC, SCLC
- VB15010Phase 21 trial
Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Cancer, Neoplasms, Neoplasms, Breast
- VLS-1488Phase 21 trial
Volastra Therapeutics, Inc. · Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.